[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357211-105":59,"doc-detail-357211-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","vitexin-attenuates-gastric-precancerous-lesions-with-egfr-as-a-potential-target-based-on-network-pharmacology-and-molecular-simulations","Vitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations","","Precancerous gastric lesions (PLGC) are a key transitional stage toward gastric cancer, but effective interventions remain limited. This study investigates vitexin, a natural flavonoid with anti-cancer potential, by identifying molecular targets and mechanisms in PLGC. An integrative workflow combines network pharmacology, protein docking, and molecular dynamics with cellular validation in MNNG-induced MC cells. Results identify EGFR as a central, functionally relevant target, showing reduced viability, migration, invasion, decreased EGFR signaling, and restored E-cadherin with EMT reversal, supporting further preclinical evaluation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vitexin-attenuates-gastric-precancerous-lesions-with-egfr-as-a-potential-target-based-on-network-pharmacology-and-molecular-simulations/357211/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vitexin-attenuates-gastric-precancerous-lesions-with-egfr-as-a-potential-target-based-on-network-pharmacology-and-molecular-simulations/357211.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address regarding PLGC and gastric cancer?","Question",{"text":112,"@type":113},"PLGC is a critical stage toward gastric cancer, yet effective ways to stop progression are limited. The study targets this gap by evaluating vitexin’s mechanisms in PLGC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers identify vitexin-related targets for PLGC?",{"text":117,"@type":113},"They intersected predicted vitexin targets with PLGC-associated genes to obtain common targets, then built a protein–protein interaction network and performed pathway enrichment analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports EGFR as a potential functional target of vitexin?",{"text":121,"@type":113},"Molecular docking and 100 ns molecular dynamics supported stable vitexin binding within the EGFR pocket. Cellular experiments showed decreased EGFR expression and EGFR-associated malignant behaviors reduced by vitexin.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357211,1790230286,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nVitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations  \nJiaying Liu1, Nan Liu1, Yiting Ye1, ZhandongYe2, Dongxu Jiang1􀀍 & Song Huang1􀀍  \nPrecancerous gastric lesions (PLGC) represent a critical transitional stage toward gastric cancer, yet effective interventions to halt progression remain limited. Vitexin, a naturally occurring flavonoid, exhibits anti-cancer potential; however, its molecular targets and mechanisms in PLGC have not been fully defined. This study aimed to elucidate the targets and mechanisms of vitexin against PLGC using an integrative strategy combining network pharmacology, molecular docking/molecular dynamics (MD), and cellular validation. Putative targets of vitexin and PLGC-associated genes were intersected to obtain 33 common targets, followed by protein–protein interaction network construction and pathway enrichment analyses. Molecular docking was performed against core targets, and MD simulations were conducted to assess the stability of the EGFR–vitexin complex. In vitro validation was carried out in MNNG-induced MC cells using cell viability, migration, and invasion assays, phasecontrast imaging, and immunofluorescence staining of EGFR and E-cadherin. Network analysis highlighted CCND1, EGFR, and ABL1 as central nodes and implicated oncogenic programs including cell-cycle regulation and PI3K–Akt signaling pathway. Docking suggested favorable binding of vitexinto the core targets. MD simulations further supported a stable binding mode of vitexin within the EGFR pocket over 100 ns with preserved global compactness; a late-stage conformational adaptation accompanied by hydrogen-bond network reorganization was observed without signs of global unfolding. Functionally, vitexin reduced MC cell viability in a dose-dependent manner, reaching ~ 50% inhibition at 20 μM, and significantly suppressed cell migration and invasion. Immunofluorescence demonstrated decreased EGFR expression and altered membrane localization, together with restored E-cadherin expression and membrane localization, suggesting a shift toward an epithelial phenotype. Vitexin inhibits PLGC-associated malignant phenotypes through multi-target modulation. Among the identified candidates, EGFR may serve as a putative and functionally relevant target, while modulation of EGFR-associated signaling together with restoration of E-cadherin may contribute to the reversal of EMT-related phenotypes. These findings provide mechanistic and structural support for the further preclinical evaluation of vitexin in preventing gastric cancer progression.  \nKeywords Vitexin, Precancerous gastric lesions, EGFR, Epithelial-mesenchymal transition, Migration, Invasion, Molecular docking, Anticancer agent  \nAbbreviations  \nCCK-8 DMSO  \nEGFR  \nEMT GES-1 cells MC  \nCell counting kit-8  \nDimethyl sulfoxide  \nEpidermal growth factor receptor Epithelial-mesenchymal transition Human gastric mucosal epithelial cell lines MNNG-induced model cells  \n1School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong, People’s Republic of China. 2Shenshan Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei 516621, Guangdong, People’s Republic of China. 􀀍 [email: jdx_gzucm@163.com](email: jdx_gzucm@163.com); [huangnn421@163.com](huangnn421@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nMNNG  \nPLGC  \nPPI  \nKEGG  \nGO  \nPI3K–Akt  \nN-Methyl-N'-nitro-N-nitrosoguanidine Precancerous lesions of gastric cancer Protein–protein interaction  \nKyoto encyclopedia of genes and genomes Gene ontology  \nPhosphoinositide 3-kinase/protein kinase B  \nGastric cancer (GC) ranks as the fifth most prevalent cancer globally and stands as the third leading cause of cancer-related mortality, underscoring the urgent need for effective interve","cbCaig9fR7YdDVZb","https://ap.wps.com/l/cbCaig9fR7YdDVZb","pdf",2906001,12,"English","# Background\n# EMT and gastric precancerous progression\n# Integrative strategy and target identification\n# Molecular docking and molecular dynamics\n# In vitro cellular validation\n# Network and pathway insights\n# Functional effects and EMT marker changes\n# Conclusion and preclinical implications","[{\"question\":\"What problem does the study address regarding PLGC and gastric cancer?\",\"answer\":\"PLGC is a critical stage toward gastric cancer, yet effective ways to stop progression are limited. The study targets this gap by evaluating vitexin’s mechanisms in PLGC.\"},{\"question\":\"How did the researchers identify vitexin-related targets for PLGC?\",\"answer\":\"They intersected predicted vitexin targets with PLGC-associated genes to obtain common targets, then built a protein–protein interaction network and performed pathway enrichment analyses.\"},{\"question\":\"What evidence supports EGFR as a potential functional target of vitexin?\",\"answer\":\"Molecular docking and 100 ns molecular dynamics supported stable vitexin binding within the EGFR pocket. Cellular experiments showed decreased EGFR expression and EGFR-associated malignant behaviors reduced by vitexin.\"}]","Vitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations | PDF",1790129351,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/934a4d71ac8d54a3f0b208b96dd50a1b.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d13f8897bc9342a70218eff4b4ae2405.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4ff3cbd6351fd378dd73180c2eb4853.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4a3a0db0984c6ab22ac6d0b502e5349.webp",980,1287]